Back to search
FDAFDA · Food and drugs·Recall number D-1185-2014

Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, Research Triangle Park, NC 27709. Made in Japan. NDC 49702-228-13

Published April 9, 2014 · Recall initiated: February 11, 2014

Summary

FDA records drug Class III recall D-1185-2014, published April 9, 2014 and initiated February 11, 2014. Recalling firm: Viiv Healthcare Company; Status: Terminated; Reported quantity: 1,056 bottles; Lot: Lot #: 3ZP2210 Sub-lot A, Expiry: 10/15. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination with Other Products: Product contains Promacta (eltrombopag).

What to do

Voluntary: Firm initiated · Letter

Get an email if TIVICAY has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TIVICAY
Manufacturer
Viiv Healthcare Company
Distributor
Nationwide including Puerto Rico
UPC
0349702227132
Lot
Lot #: 3ZP2210 Sub-lot A, Expiry: 10/15
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, Research Triangle Park, NC 27709. Made in Japan. NDC 49702-228-13 recalled?

Yes. FDA published recall D-1185-2014 on April 9, 2014. Reported hazard: Cross Contamination with Other Products: Product contains Promacta (eltrombopag).

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TIVICAY. UPC: 0349702227132.